In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
HIGHLIGHTS
EVENTS
EIGHT, the global educational initiative on Hemophilia A and its treatment
Experts from all over the world attended the EIGHT 2018 Conference in Budapest, Hungary on 12-13 October
read moreEVENTS
Kedrion Biopharma participates in the Mother and Child Conference in Moscow
A 50 years of Anti-D dedicated programme presented at the main Russian congress of Gynecology and Obstetrics
read moreEVENTS
Kedrion Joins Annual PNS Conference on Neurology
The company took part in the event with a booth and a delegation of 40 int’l guests
read more-
CORPORATE - 10-01-2018
Hemophilia: Kedrion signs on to groundbreaking PARTNERS programme
Goal is to improve access to replacement therapies for coagulation disorders in Europe
read more -
EVENTS - 09-11-2017
Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius
This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs
read more -
CORPORATE - 31-10-2017
Kedrion and Cerus enter distribution agreement for INTERCEPT in Italy
Agreement covers complete INTERCEPT product line: platelets, plasma and red blood cells
read more -
CORPORATE - 25-08-2017
Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®
The product is approved for post-exposure prophylaxis against rabies infection
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 